A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)

Annals of the Rheumatic Diseases

Volumn 70, Issue 5, 2011, Pages 747-754

  Quartier, Pierre ^a   Allantaz, Florence ^b   Cimaz, Rolando ^c   Pillet, Pascal ^d   Messiaen, Claude ^a   Bardin, Christophe ^e   Bossuyt, Xavier ^f   Boutten, Anne ^g   Bienvenu, Jacques ^h   Duquesne, Agnes ^c   Richer, Olivier ^d   Chaussabel, Damien ^b   Mogenet, Agnes ^a   Banchereau, Jacques ^b,i,j   Treluyer, Jean Marc ^a   Landais, Paul ^a   Pascual, Virginia ^b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b BAYLOR INSTITUTE FOR IMMUNOLOGY RESEARCH   (United States)

^c HOSPICES CIVILS DE LYON   (France)

^d HÔPITAL PELLEGRIN   (France)

^e HÔTEL DIEU   (France)

^f UNIVERSITY OF LEUVEN   (Belgium)

^g BICHAT HOSPITAL   (France)

^h UNIVERSITÉ DE LYON   (France)

ⁱ INSERM Unit 899   (United States)

^j MOUNT SINAI SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INTERFERON; PLACEBO; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASTHENIA; BACKACHE; BRONCHITIS; CANDIDIASIS; CHICKENPOX; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERANCE; DRUG WITHDRAWAL; EAR INFECTION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FEVER; GASTROENTERITIS; GENE EXPRESSION PROFILING; HEMATURIA; HUMAN; INFECTION; INJECTION SITE REACTION; JUVENILE RHEUMATOID ARTHRITIS; LARYNGITIS; MALE; MULTICENTER STUDY; NOSE INFECTION; PHARYNGITIS; PNEUMONIA; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SIDE EFFECT; SKIN DEFECT; SKIN INFECTION; TOOTH FRACTURE; TREATMENT RESPONSE; URINARY TRACT INFECTION; VERTIGO; VOMITING;

ADOLESCENT; ANTIBODIES, BACTERIAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, JUVENILE RHEUMATOID; BIOLOGICAL MARKERS; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; CHILD; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; FEMALE; GENE EXPRESSION PROFILING; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MALE; PNEUMOCOCCAL VACCINES; POLYSACCHARIDES, BACTERIAL; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79953323633     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2010.134254     Document Type: Article

References (30)

1. Petty RE, Southwood TR, Manners P, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004;31:390-2. (Pubitemid 38160763)
2. Woo P, Southwood TR, Prieur AM, et al. Randomized, placebo-controlled, crossover trial of low-dose oral methotrexate in children with extended oligoarticular or systemic arthritis. Arthritis Rheum 2000;43:1849-57.
3. Quartier P, Taupin P, Bourdeaut F, et al. Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type. Arthritis Rheum 2003;48:1093-101. (Pubitemid 36418252)
4. Yokota S, Imagawa T, Mori M, et al. Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis:a randomised, double-blind, placebo-controlled, withdrawal phase III trial. Lancet 2008;371:998-1006. (Pubitemid 351389534)
5. Spiegel LR, Schneider R, Lang BA, et al. Early predictors of poor functional outcome in systemic-onset juvenile rheumatoid arthritis:a multicenter cohort study. Arthritis Rheum 2000;43:2402-9.
6. Pascual V, Allantaz F, Arce E, et al. Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade. J Exp Med 2005;201:1479-86. (Pubitemid 40664091)
7. Allantaz F, Chaussabel D, Stichweh D, et al. Blood leukocyte microarrays to diagnose systemic onset juvenile idiopathic arthritis and follow the response to IL-1 blockade. J Exp Med 2007;204:2131-44. (Pubitemid 47360874)
8. LequerréT, Quartier P, Rosellini D, et al. Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France. Ann Rheum Dis 2008;67:302-8.
9. Gattorno M, Piccini A, LasiglièD, et al. The pattern of response to anti-interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 2008;58:1505-15. (Pubitemid 351705940)
10. Zeft A, Hollister R, LaFleur B, et al. Anakinra for systemic juvenile arthritis: the Rocky Mountain experience. J Clin Rheumatol 2009;15:161-4.
11. Worwood M, Cragg SJ, Wagstaff M, et al. Binding of human serum ferritin to concanavalin A. Clin Sci 1979;56:83-7. (Pubitemid 10150752)
12. Vignes S, Le Moël G, Fautrel B, et al. Percentage of glycosylated serum ferritin remains low throughout the course of adult onset Still's disease. Ann Rheum Dis 2000;59:347-50.
13. Jeurissen A, Moens L, Raes M, et al. Laboratory diagnosis of specific antibody deficiency to pneumococcal capsular polysaccharide antigens. Clin Chem 2007;53:505-10. (Pubitemid 46447948)
14. Chaussabel D, Quinn C, Shen J, et al. A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus. Immunity 2008;29:150-64. (Pubitemid 351952461)
15. Giannini EH, Ruperto N, Ravelli A, et al. Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum 1997;40:1202-9. (Pubitemid 27430130)
16. Wallace CA, Ruperto N, Giannini E. Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis. J Rheumatol 2004;31:2290-4. (Pubitemid 39453253)
17. Solle M, Labasi J, Perregaux DG, et al. Altered cytokine production in mice lacking P2X(7) receptors. J Biol Chem 2001;276:125-32. (Pubitemid 32050297)
18. Ilowite N, Porras O, Reiff A, et al. Anakinra in the treatment of polyarticular-course juvenile rheumatoid arthritis:safety and preliminary efficacy results of a randomized multicenter study. Clin Rheumatol 2009;28:129-37.
19. Salliot C, Dougados M, Gossec L. Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis:meta- analyses of randomised placebo-controlled trials. Ann Rheum Dis 2009;68:25-32.
20. Ruemmele FM, Prieur AM, Talbotec C, et al. Development of Crohn disease during anti-TNF-alpha therapy in a child with juvenile idiopathic arthritis. J Pediatr Gastroenterol Nutr 2004;39:203-6.
21. Dallocchio A, Canioni D, Ruemmele F, et al. Occurrence of inflammatory bowel disease during treatment of juvenile idiopathic arthritis with etanercept: a French retrospective study. Rheumatology (Oxford) 2010;49:1694-8.
22. Martinon F, Mayor A, Tschopp J. The inflammasomes: guardians of the body. Annu Rev Immunol 2009;27:229-65.
23. Fall N, Barnes M, Thornton S, et al. Gene expression profiling of peripheral blood from patients with untreated new-onset systemic juvenile idiopathic arthritis reveals molecular heterogeneity that may predict macrophage activation syndrome. Arthritis Rheum 2007;56:3793-804. (Pubitemid 350100712)
24. Palucka AK, Blanck JP, Bennett L, et al. Cross-regulation of TNF and IFN-alpha in autoimmune diseases. Proc Natl Acad Sci USA 2005;102:3372-7. (Pubitemid 40328052)
25. Ogilvie EM, Khan A, Hubank M, et al. Specific gene expression profiles in systemic juvenile idiopathic arthritis. Arthritis Rheum 2007;56:1954-65. (Pubitemid 47110394)
26. Wong PK, Egan PJ, Croker BA, et al. SOCS-3 negatively regulates innate and adaptive immune mechanisms in acute IL-1-dependent inflammatory arthritis. J Clin Invest 2006;116:1571-81.
27. Pauli EK, Schmolke M, Wolff T, et al. Influenza A virus inhibits type I IFN signaling via NF-kappaB-dependent induction of SOCS-3 expression. PLoS Pathog 2008;4:e1000196.
28. Martinelli S, Urosevic M, Daryadel A, et al. Induction of genes mediating interferon-dependent extracellular trap formation during neutrophil differentiation. J Biol Chem 2004;279:44123-32. (Pubitemid 39390721)
29. Pascual V, Farkas L, Banchereau J. Systemic lupus erythematosus: all roads lead to type I interferons. Curr Opin Immunol 2006;18:676-82. (Pubitemid 44635182)
30. Dinarello CA. Interleukin-1beta and the autoinflammatory diseases. N Engl J Med 2009;360:2467-70.